Bladder Cancer

Viewing 1-8 of 8 articles

SCS AUA 2022: Management, Surveillance Patterns, and Costs Associated With Low-grade Papillary (Ta) Nonmuscle-invasive Bladder Cancer

SCS AUA 2022: Expanding the Use of Bladder Preservation Options for Muscle Invasive Bladder Cancer

SCS AUA 2022: Two-Year Resource Utilization of Open vs. Robot-Assisted Radical Cystectomy: Results From The Optum Clinformatics DataMart Claims Database

SCS AUA 2022: Context-based Identification of Muscle-Invasion Status in Bladder Cancer Patients Using Natural Language Processing

SCS AUA 2022: Evaluation in the Differences of Surgical Site Complication Rates in Robotic Assisted Radical Cystectomy and Open Radical Cystectomy

SCS AUA 2022: Comparison of Apixaban Vs Enoxaparin for Extended Venous Thromboembolism

SCS AUA 2022: Long Term Cost Comparisons of Radical Cystectomy Versus Trimodal Therapy

SCS AUA 2022: Long-Term Healthcare Costs for Patients Undergoing Radical Cystectomy for Bladder Cancer: Results From a Population-Based Cohort From Privately Insured Patients